{"version":"1.0","type":"link","title":"Radioenhancing Hafnium Oxide Nanoparticles (NBTXR3) Followed by Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma and Liver Metastases (NBTXR3-103): Phase 1 Dose-Escalation Trial.","author_name":"Chajon E 외","author_url":"https://prs-insight.online/author/Chajon%20E","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/112264","thumbnail_width":1200,"thumbnail_height":630}